SynthesisClinical cardiology2021

Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta-analysis.

Cheng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.